Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway

Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway

Haoyue Hu,1,* Yanyang Liu,1,* Songtao Tan,1,* Xiao Xiao Xie,1 Jun He,1,2 Feng Luo,1 Li Wang1 1Lung Cancer Center, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, People’s Republic of China; 2Department of Oncology, The Third H...

Full description

Bibliographic Details
Main Authors: Hu H, Liu Y, Tan S, Xie XX, He J, Luo F, Wang L
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:Cancer Management and Research
Subjects:
anlotinib
kras-mutated
lung cancer
signal pathways
Online Access:https://www.dovepress.com/anlotinib-exerts-anti-cancer-effects-on-kras-mutated-lung-cancer-cell--peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/anlotinib-exerts-anti-cancer-effects-on-kras-mutated-lung-cancer-cell--peer-reviewed-article-CMAR

Similar Items